Log in to save to my catalogue

An inhibitor of oxidative phosphorylation exploits cancer vulnerability

An inhibitor of oxidative phosphorylation exploits cancer vulnerability

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2054962645

Publication information

Publisher

New York: Nature Publishing Group US

More information

Scope and Contents

Contents

Metabolic reprograming is an emerging hallmark of tumor biology and an actively pursued opportunity in discovery of oncology drugs. Extensive efforts have focused on therapeutic targeting of glycolysis, whereas drugging mitochondrial oxidative phosphorylation (OXPHOS) has remained largely unexplored, partly owing to an incomplete understanding of t...

Alternative Titles

Full title

An inhibitor of oxidative phosphorylation exploits cancer vulnerability

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2054962645

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2054962645

Other Identifiers

ISSN

1078-8956

E-ISSN

1546-170X

DOI

10.1038/s41591-018-0052-4

How to access this item